Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Winer

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Hematology/Oncology Clinics of North America|February 25, 2020
Secondary Acute Myeloid Leukemia: A Primary Challenge of Diagnosis and TreatmentEric S Winer
Medicine and Health, Rhode Island|February 5, 2011
Chronic lymphocytic leukemia: something old, something new and something borrowedKimberly Perez, Eric S Winer
Primary Care|November 22, 2016
Leukocytosis and LeukemiaPage Widick, Eric S Winer
Blood Advances|January 28, 2025
Things (like AML salvage) go better with VEN(etoclax)Eric S Winer, Richard M Stone
Therapeutic Advances in Hematology|July 20, 2019
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approachesEric S Winer, Richard M Stone
Rhode Island Medical Journal (2013)|October 31, 2015
Genomics in acute myeloid leukemia: from identification to personalizationJames M Martin, Eric S Winer
Oncology and Therapy|July 24, 2020
A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment ResurrectedEric S Winer, Daniel J DeAngelo
Current Oncology Reports|October 17, 2024
AML in the Elderly - When less may be moreEric S Winer, Richard M Stone
Expert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S Winer
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemiaAhmad Alduaij, Diana O Treaba, Eric S Winer
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Hematology/Oncology Clinics of North America|February 25, 2020
Secondary Acute Myeloid Leukemia: A Primary Challenge of Diagnosis and TreatmentEric S Winer
Medicine and Health, Rhode Island|February 5, 2011
Chronic lymphocytic leukemia: something old, something new and something borrowedKimberly Perez, Eric S Winer
Primary Care|November 22, 2016
Leukocytosis and LeukemiaPage Widick, Eric S Winer
Blood Advances|January 28, 2025
Things (like AML salvage) go better with VEN(etoclax)Eric S Winer, Richard M Stone
Therapeutic Advances in Hematology|July 20, 2019
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approachesEric S Winer, Richard M Stone
Rhode Island Medical Journal (2013)|October 31, 2015
Genomics in acute myeloid leukemia: from identification to personalizationJames M Martin, Eric S Winer
Oncology and Therapy|July 24, 2020
A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment ResurrectedEric S Winer, Daniel J DeAngelo
Current Oncology Reports|October 17, 2024
AML in the Elderly - When less may be moreEric S Winer, Richard M Stone
Expert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S Winer
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemiaAhmad Alduaij, Diana O Treaba, Eric S Winer
Pageof 8